BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32204324)

  • 21. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foamy virus vectors.
    Mergia A; Heinkelein M
    Curr Top Microbiol Immunol; 2003; 277():131-59. PubMed ID: 12908771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foamy-virus-mediated gene transfer to canine repopulating cells.
    Kiem HP; Allen J; Trobridge G; Olson E; Keyser K; Peterson L; Russell DW
    Blood; 2007 Jan; 109(1):65-70. PubMed ID: 16968897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-Vivo Gene Therapy with Foamy Virus Vectors.
    Rajawat YS; Humbert O; Kiem HP
    Viruses; 2019 Nov; 11(12):. PubMed ID: 31771194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
    Leurs C; Jansen M; Pollok KE; Heinkelein M; Schmidt M; Wissler M; Lindemann D; Von Kalle C; Rethwilm A; Williams DA; Hanenberg H
    Hum Gene Ther; 2003 Apr; 14(6):509-19. PubMed ID: 12718762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a Dual-Vector System for Gene Delivery Utilizing Prototype Foamy Virus.
    Cho SY; Lee YJ; Jung SM; Son YM; Shin CG; Kim ET; Kim KD
    J Microbiol Biotechnol; 2024 Apr; 34(4):804-811. PubMed ID: 38379304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of foamy virus vector and transduction of hematopoietic cells.
    Josephson NC; Russell DW
    Cold Spring Harb Protoc; 2010 Sep; 2010(9):pdb.prot5481. PubMed ID: 20810629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of foamy virus vectors.
    Vassilopoulos G; Josephson NC; Trobridge G
    Methods Mol Med; 2003; 76():545-64. PubMed ID: 12526184
    [No Abstract]   [Full Text] [Related]  

  • 29. Transduction of human neural progenitor cells with foamy virus vectors for differentiation-dependent gene expression.
    Rothenaigner I; Kramer S; Meggendorfer M; Rethwilm A; Brack-Werner R
    Gene Ther; 2009 Mar; 16(3):349-58. PubMed ID: 19052634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foamy virus biology and its application for vector development.
    Lindemann D; Rethwilm A
    Viruses; 2011 May; 3(5):561-85. PubMed ID: 21994746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.
    Hamann MV; Stanke N; Müllers E; Stirnnagel K; Hütter S; Artegiani B; Bragado Alonso S; Calegari F; Lindemann D
    Mol Ther; 2014 Aug; 22(8):1460-1471. PubMed ID: 24814152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral Infection of Mouse Bone Marrow Cells for Hematopoietic Stem Cell Transplantation.
    Chen C; Guderyon MJ; Ge G; Clark RA; Li S
    Methods Mol Biol; 2019; 1919():205-213. PubMed ID: 30656632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feline foamy virus-based vectors: advantages of an authentic animal model.
    Liu W; Lei J; Liu Y; Lukic DS; Räthe AM; Bao Q; Kehl T; Bleiholder A; Hechler T; Löchelt M
    Viruses; 2013 Jul; 5(7):1702-18. PubMed ID: 23857307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transduction of long-term and mobilized peripheral blood-derived NOD/SCID repopulating cells by foamy virus vectors.
    Josephson NC; Trobridge G; Russell DW
    Hum Gene Ther; 2004 Jan; 15(1):87-92. PubMed ID: 14965380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transduction of human embryonic stem cells by foamy virus vectors.
    Gharwan H; Hirata RK; Wang P; Richard RE; Wang L; Olson E; Allen J; Ware CB; Russell DW
    Mol Ther; 2007 Oct; 15(10):1827-33. PubMed ID: 17622243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.
    Doering CB; Archer D; Spencer HT
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1204-12. PubMed ID: 20869414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo gene delivery into hCD34+ cells in a humanized mouse model.
    Frecha C; Fusil F; Cosset FL; Verhoeyen E
    Methods Mol Biol; 2011; 737():367-90. PubMed ID: 21590405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors.
    Rethwilm A
    Curr Gene Ther; 2007 Aug; 7(4):261-71. PubMed ID: 17969559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in Gene Therapy for Fanconi Anemia.
    Río P; Navarro S; Bueren JA
    Hum Gene Ther; 2018 Oct; 29(10):1114-1123. PubMed ID: 30117331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Foamy viral vector integration sites in SCID-repopulating cells after MGMTP140K-mediated in vivo selection.
    Olszko ME; Adair JE; Linde I; Rae DT; Trobridge P; Hocum JD; Rawlings DJ; Kiem HP; Trobridge GD
    Gene Ther; 2015 Jul; 22(7):591-5. PubMed ID: 25786870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.